Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Frances McMullin

Showing results (1-10 of 163) with videos related to

Pageof 17
Sort By:
Expert Review of Hematology|November 19, 2010
HIF pathway mutations and erythrocytosisMary Frances McMullin
Journal of Clinical Pathology|October 27, 2017
70 years of the <i>JCP</i>-highly cited papers: Proposals for the classification of chronic (mature) B and T lymphoid leukaemiasMary Frances McMullin
Genes|August 27, 2021
Genetic Background of Congenital ErythrocytosisMary Frances McMullin
Clinical Chemistry|January 31, 2012
CommentaryMary Frances McMullin
Blood|November 8, 2019
Reducing the burden of MPNMary Frances McMullin
The Ulster Medical Journal|October 23, 2020
Presidential address to the Ulster Medical Society on 3rd October 2019Mary Frances McMullin
Therapeutic Advances in Hematology|April 23, 2013
Diagnosis and management of congenital and idiopathic erythrocytosisMary Frances McMullin
Hematology. American Society of Hematology. Education Program|December 17, 2009
Idiopathic erythrocytosis: a disappearing entityMary Frances McMullin
Hematology. American Society of Hematology. Education Program|December 7, 2019
Diagnostic workflow for hereditary erythrocytosis and thrombocytosisMary Frances McMullin
Hematological Oncology|March 14, 2007
A review of the therapeutic agents used in the management of polycythaemia veraMary Frances McMullin
Pageof 17

Showing results (1-10 of 163) with videos related to

Sort By:
Pageof 17
Expert Review of Hematology|November 19, 2010
HIF pathway mutations and erythrocytosisMary Frances McMullin
Journal of Clinical Pathology|October 27, 2017
70 years of the <i>JCP</i>-highly cited papers: Proposals for the classification of chronic (mature) B and T lymphoid leukaemiasMary Frances McMullin
Genes|August 27, 2021
Genetic Background of Congenital ErythrocytosisMary Frances McMullin
Clinical Chemistry|January 31, 2012
CommentaryMary Frances McMullin
Blood|November 8, 2019
Reducing the burden of MPNMary Frances McMullin
The Ulster Medical Journal|October 23, 2020
Presidential address to the Ulster Medical Society on 3rd October 2019Mary Frances McMullin
Therapeutic Advances in Hematology|April 23, 2013
Diagnosis and management of congenital and idiopathic erythrocytosisMary Frances McMullin
Hematology. American Society of Hematology. Education Program|December 17, 2009
Idiopathic erythrocytosis: a disappearing entityMary Frances McMullin
Hematology. American Society of Hematology. Education Program|December 7, 2019
Diagnostic workflow for hereditary erythrocytosis and thrombocytosisMary Frances McMullin
Hematological Oncology|March 14, 2007
A review of the therapeutic agents used in the management of polycythaemia veraMary Frances McMullin
Pageof 17